Aspire Biopharma Holdings, Inc. develops a sublingual drug delivery technology that enhances the efficacy of existing medications for pain management and inflammation. The company focuses on creating formulations that allow for rapid absorption of drugs under the tongue, bypassing the gastrointestinal tract to improve treatment response times. Aspire Biopharma's technology can be applied to various proven drugs and supplements, including analgesics and medications for erectile dysfunction and traumatic brain injury.
No recent RNS announcements for ASBP across ASBP, ASBPW.
No recent RNS announcements for ASBP across ASBP, ASBPW.